J. David Owens

David is an experienced leader in the pharmaceutical and biotech industry with extensive expertise in the commercialization of biopharmaceuticals and biologicals.

He co-founded a venture-backed company (TriGenix) and has also formed new business units and driven growth into existing large franchises for several biopharmaceutical companies. Most recently, David built the Hospital & Surgical Products Division at King Pharmaceuticals, and prior to that held multiple franchise management roles at Aventis Pharma, including Vice President of Global Marketing and Medical Affairs. Earlier in his career, David had commercial roles at Genentech, Merck and Abbott Labs.

He is also a limited partner in the Mid-Atlantic Angel Group (MAG) Fund and a Business Advisor to the University City Science Center QED Program.

J. David Owens is the Member at Delaware Crossing Investor Group, based in United States, North America.J. David Owens studied unknown Pharmacy at University of Wisconsin-Madison. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.